David A. Rubenstein
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 14
- Surgery 20
- Coronary Interventions and Diagnostics 11
- Co-authors
- Wei Yin (47 shared papers)J. Radziuk (1 shared paper)John Dupré (1 shared paper)Timothy J. McDonald (1 shared paper)Berhane Ghebrehiwet (10 shared papers)Jolyon Jesty (4 shared papers)Danny Bluestein (2 shared papers)Hongbing Lu (5 shared papers)
- Journals
- The FASEB Journal (6 papers)Journal of Biomechanical Engineering (4 papers)Platelets (4 papers)Cellular and Molecular Bioengineering (4 papers)Thrombosis Research (3 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
David A. Rubenstein
84 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 140
- Hematology 182
- Clinical Biochemistry 103
- Physiology 387
- Cardiology and Cardiovascular Medicine 338
- Internal Medicine 43
Countries citing papers authored by David A. Rubenstein
This map shows the geographic impact of David A. Rubenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Rubenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Rubenstein more than expected).
Fields of papers citing papers by David A. Rubenstein
This network shows the impact of papers produced by David A. Rubenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Rubenstein. The network helps show where David A. Rubenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Rubenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1978 | 182 | |
| 2 | 2017 | 136 | |
| 3 | 2016 | 103 | |
| 4 | 2003 | 84 | |
| 5 | 2010 | 70 | |
| 6 | 2008 | 61 | |
| 7 | 2018 | 59 | |
| 8 | 2015 | 52 | |
| 9 | 2010 | 49 | |
| 10 | 2009 | 44 | |
| 11 | 1970 | 43 | |
| 12 | 2021 | 38 | |
| 13 | 2011 | 38 | |
| 14 | 1996 | 37 | |
| 15 | 2010 | 35 | |
| 16 | 2007 | 34 | |
| 17 | 2019 | 33 | |
| 18 | 2009 | 30 | |
| 19 | 2013 | 29 | |
| 20 | 2014 | 27 |
About David A. Rubenstein
David A. Rubenstein is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Hematology, Biomedical Engineering and Physiology, having authored 86 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Platelet Disorders and Treatments (13 papers), Coronary Interventions and Diagnostics (11 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers), Advanced Glycation End Products research (8 papers), Electrospun Nanofibers in Biomedical Applications (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Smoking Behavior and Cessation (6 papers). The work is most often cited by research in Hematology (182 citations), Clinical Biochemistry (103 citations), Physiology (387 citations), Cardiology and Cardiovascular Medicine (338 citations) and Internal Medicine (43 citations). David A. Rubenstein has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Wei Yin, J. Radziuk, John Dupré, Timothy J. McDonald, Berhane Ghebrehiwet, Jolyon Jesty, Danny Bluestein, Hongbing Lu, Li Chen and Mary D. Frame. Their work appears in journals such as The FASEB Journal, Journal of Biomechanical Engineering, Platelets, Cellular and Molecular Bioengineering and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.